| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.09 |